NFE2 and deep vein thrombosis: Patients with NFE2 gene mutations had a higher incidence of pre-diagnosis thrombosis(39.0% vs 22.0%, P=0.012)and pre-diagnosis arterial thrombosis(36.6% vs 20.4%, P=0.014).